  The translation workplace | |||
| |||
| |||||||||
Login or register (free and only takes a few minutes) to participate in this question.You will also have access to many other tools and opportunities designed for those who have language-related jobs(or are passionate about them). Participation is free and the site has a strict confidentiality policy.
2 days1 hr confidence:  
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
22 hrs peer agreement (net): +1 |
| Reference: global value dossier Reference information: Ik heb nog geen NL equivalent kunnen vinden, maar een GVD lijkt betrekking te hebben op producten, eerder dan op mensen. Zie bijvoorbeeld onderstaande links. Overigens lijkt mij dat "Globaal Medisch Dossier" de Belgische tegenhanger is van NL Electronisch Patiëntendossier, maar daar mag door collegae gerust op geschoten worden, want dat weet ik niet 100% zeker. http://md.covance.com/insights/1q07/outinfront.htm "Caroline Schaefer presented “Using a global value dossier to support a successful global launch” at CBI's Pharmaceutical Product Launches, West Conshohocken, PA, December 5-6, 2006" -------------- http://www.abtbiopharma.com/advantage/exp_musculo.html "Global value dossier for a novel product indicated for treatment of a subtype of juvenile arthritis." -------------- http://www.prmaconsulting.com/global_value_dossiers.html Global Value Dossiers PRMA consulting™ has significant experience of developing Global Value Dossiers (GVD) for a range of diseases and products. Structured around the key value messages for the disease and the product, the key sections of the GVD include: The Value Story comprising a standalone summary of the products evidence-based value proposition in the disease. The Problem Section structured around the key value messages including: • An overview of the disease and the way the it is managed • Burden of illness and unmet needs • Available treatments and available information (clinical, HRQOL, health economic). The Solution Section structured around the key value messages including: • A short description of the product • Clinical, safety and HRQOL data available for the product • An overview of ongoing studies. The Economic Value Section which is structured around key value messages and includes cost-effectiveness and budget impact data available for the product as well as References, Glossary and abbreviations. ---------------- http://www.ispor.org/employment/JobDetails.aspx?guid=cd8ed1b... The candidate will be responsible for supporting, planning, implementing, and delivering SBU Market Access (MAx) platform work which encompasses Health Technology Assessment (HTA)/Evidence-based Medicine (EBM) dossiers/briefing, AMCP/Global Value Dossiers, Healthcare Policy initiatives .... These activities help develop and otherwise support the global market access strategy, payer value propositions, early development decisions, and/or licensing/acquisition/partnership decisions for products across, relevant to the Specialty portfolio -------------------------------------------------- Note added at 23 hrs (2010-04-05 15:03:07 GMT) -------------------------------------------------- http://www.assessment-in-medicine.de/cms/upload/PDF/AiM_Capa... Definition: “ A global value dossier focuses on one product and summarizes all valuable and relevant information in order to inform decision makers and health care payers from a global perspective. “ |
| |
| Login to enter a peer comment (or grade) | ||
 |
